Adverse Event Reporting: Getting started Lynn Bahta, R.N., B.S.N Minnesota Department of Health August 2008.

Slides:



Advertisements
Similar presentations
Tips and Resources IASC Cluster/Sector Leadership Training
Advertisements

SAFETY NET NETWORK LEADERSHIP AND ADVISORY GROUP MEETING Wednesday, June 19, 2013.
For Official Use Only. Public Health and EMS How Long Do You Have to Live? For Official Use Only.
TM Aggregate Reporting of Pandemic Influenza Vaccine Doses Administered Discussion of Options 2 & 3: Submitting Aggregate Reports using the Web-Based User.
Maryland 2008 Statewide Pandemic Influenza Exercise and CRA Albert Romanosky MD, PhD Office of Preparedness and Response Maryland Department of Health.
Julianne Gee, MPH Immunization Safety Office
Influenza Vaccine Surveillance System Pilot Project Pandemic Influenza Vaccine: Doses Administered and Safety Training Conference Atlanta, GA—Aug. 22,
Local Health Department Perspective Electronic Medical Record Software and Health Information Exchanges Kathleen Cook Information & Fiscal Manager, Lincoln-Lancaster.
1 Proposed Pharmacovigilance Plan for H5N1 Influenza Virus Vaccine Patrick Caubel, MD, PhD Head of Pharmacovigilance North America February 27, 2007.
1 Antivirals in the Draft CDC Pandemic Plan David K. Shay Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention.
Capability Cliff Notes Series PHEP Capability 8—Medical Dispensing and Countermeasures What Is It And How Will We Measure It?
North Carolina Immunization Program (NCIP) Overview
Project Immunize Virginia Diane Helentjaris, MD, MPH Director, Office of H1N1 Response Virginia Department of Health March 25, 2010 West Henrico Health.
To protect the health and environment of all Kansans by promoting responsible choices. Immunization Program 2009 H1N1 Adventure Governor’s Child Health.
Introduction to Developing a Vaccination Strategy for Smallpox Preparedness Department of Health and Human Services Centers for Disease Control and Prevention.
Health Departments and Healthcare-Associated Infection Prevention Research: A New Land of Opportunity? Matthew Wise, MPH, PhD Epidemiologist, Office of.
TM Aggregate Reporting of Pandemic Influenza Vaccine Doses Administered Joint Presentation by: Immunization Services Division National Center for Immunization.
TM Aggregate Reporting of Pandemic Influenza Vaccine Doses Administered Planning for Seasonal Influenza Pilot Test as Proxy Using CDC's Countermeasure.
Minnesota Healthcare Setting Employee Influenza Vaccination Program Survey Denise Dunn, RN, MPH Adult/Adolescent Immunization Coordinator Minnesota Department.
Building Public Health / Clinical Health Information Exchanges: The Minnesota Experience Marty LaVenture, MPH, PhD Director, Center for Health Informatics.
The Quality Management System
HealthSanté CanadaCanada Influenza Prevention and Control in Canada Arlene King, MD, MHSc, FRCPC Director, Immunization and Respiratory Infections Division,
TM Aggregate Reporting of Pandemic Influenza Vaccine Doses Administered Status and Open Q&A Joint Presentation by: Immunization Services Division National.
Strategic Plan Evidence, knowledge and action for a healthier Ontario October 2, 2013 Presentation to ANDSOOHA.
Smallpox Vaccine Safety and Reporting Adverse Events Department of Health and Human Services Centers for Disease Control and Prevention February 2003.
Integrating Behavioral Health and Medical Health Care.
Bee Wise Immunize Governor’s Child Health Advisory Committee Immunization Workgroup Topeka, KS April 29, 2011 Sue Bowden, RN, BS Director, KDHE Immunization.
THE NATIONAL INFLUENZA VACCINE SUMMIT: UPDATE Raymond A. Strikas, M.D. Immunization Services Division National Immunization Program Coordinating Center.
Smallpox Vaccine Program: Communications with the Public and Stakeholders Department of Health and Human Services Centers for Disease Control and Prevention.
Office of Public Health Preparedness and Response Division of Strategic National Stockpile Ben Erickson Public Health Analyst Inventory Management Tracking,
ASDPE Asia Pacific Strategy for Emerging Diseases (2010) and Influenza Activities Health Security and Emergencies (DSE) WHO Western Pacific Regional Office.
Hospital Outreach Unit: Local public health and HAIs Dawn Terashita MD, MPH Acute Communicable Disease Control Los Angeles County Department of Public.
Result of gap analysis and framework of action required in coming five months August rd Meeting of National Influenza Centres in the Western.
Assessing Hospital and Health System Preparedness and Response Helen Burstin, M.D., M.P.H. Director Center for Primary Care Research Agency for Healthcare.
America Responds: An HHS 2009-H1N1 Retrospective to Advance All Hazards Preparedness Discussion with the National Vaccine Advisory Committee June 3, 2010.
BIOTERRORISM AND LEGAL ISSUES: THE TEXAS EXPERIENCE NGA REGIONAL BIOTERRORISM WORKSHOP March 15, 2004 Susan K. Steeg General Counsel Texas Department of.
Smallpox Vaccine Safety and Reporting Adverse Events Department of Health and Human Services Centers for Disease Control and Prevention December 2002.
(Slide 1 of 22) Response to the National Vaccine Advisory Committee Recommendations on the Immunization Safety Office Scientific Agenda Frank DeStefano,
Informatics Activities to Support the H1N1 Vaccination Campaign Loretta A. Santilli, M.P.H. NYSIIS Program Manager.
Exposure Rostering: Population Tracking Following a Disaster Melissa E. Powell, MPH Michelle F. Barber, MS Preparedness, Surveillance & Epidemiology PUBLIC.
Anne Foley Senior Advisor, Ministry of Health New Zealand Framework for Dementia Care.
Strengthening the Delivery of New Vaccines for Adolescents A National Stakeholders' Meeting Washington DC June 2-3, 2005.
HRSA Health Disparities Collaboratives 2006: Perinatal & Patient Safety Pilot Ada Determan, M.P.H Division of Clinical Quality Bureau of Primary Health.
Older People’s Services The Single Assessment Process.
TM 1 Tracking Novel Influenza A H1N1 Vaccine Doses Administered May 13, 2009 Presentation by Division of Emergency Preparedness and Response National Center.
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
What to do before you have a Registry?: Provider Preparation Presentation to 2002 National Immunization Registry Conference October 28-30, 2002 Philadelphia.
Pandemic Influenza: Planning and Preparedness Ben Schwartz, M.D. National Vaccine Program Office, U.S. Department of Health and Human Services NVAC Meeting,
THE NATIONAL VACCINE PROGRAM OFFICE NATIONAL ADULT IMMUNIZATION PLAN OVERVIEW.
8/18/09 Novel A (H1NI) Influenza Vaccination August 18, 2009 Massachusetts Department of Public Health.
Disseminating Evidence-Based Strategies Associated With Improved Immunization Rates Denise H. Benkel, MD, MPH Bureau of Immunization New York City Department.
Increased # of AI/AN receiving in- home environmental assessment and trigger reduction education and asthma self-management education Increased # of tribal.
Experience with Pediatric Influenza Mass Immunization Clinics Karen Rea, MSN, RN, BC Kristin Kazem, CHES.
2004 Influenza: The Best of Times, the Worst of Times Kristen Ehresmann, R.N., M.P.H. Minnesota Department of Health March 2005.
Influenza Communication in Michigan: How Existing Partnerships Were Utilized and Strengthened during the 2009 Influenza Pandemic National Immunization.
Efforts to Increase Sustainable Influenza Vaccination Coverage in Pierce County, Washington Emily Less Public Health Associate Office for State, Tribal,
Nelson Arboleda, MD, MPH Immunization Safety Office (ISO) Office of the Chief Science officer (OCSO/OD) Centers for Disease Control and Prevention (CDC)
National Immunization Conference April 19, 2010
Streamlining Vaccine Ordering and Improving VFC Accountability
State Oral Health Programs and Primary Care Agency Collaborations
Overview of Pandemic Influenza Planning Guide for SLTT
National STD Prevention Conference
Childhood Immunization Rates
The Ontario Experience National Immunization Conference
U.S. Influenza Sentinel Provider Surveillance Network
11 iii. Define management and supervision roles and responsibilities
Broader Horizons for Immunization:
Continuous Quality Improvement: Making follow-up work
Kalamazoo County Adult Immunization Task Force
Immunization Safety Office (ISO) National Immunization Program (NIP)
Presentation transcript:

Adverse Event Reporting: Getting started Lynn Bahta, R.N., B.S.N Minnesota Department of Health August 2008

Early promptings Growing interest in vaccine safety issues in Minnesota –Very active and articulate anti-vaccine groups –Safety questions raised about new vaccines Request for Vaccine Safety Coordinator –Prompted further inquiry –Catalyst to set up workgroup

Birth of the Adverse Event Workgroup Determine which program should house activities –Immunization program or –Office of Emergency Preparedness Assess current resource strengths and weaknesses Identify who the key staff would be

Which program should conduct adverse event activities?

Office of Emergency Preparedness Capacity to response in large events Infrastructure exists for mass communication to both hospitals and providers Mass Prophylaxis Coordinator, originally housed in immunization, has strong clinical background

Immunization Program Basic infrastructure and knowledge already exists Relationships with vaccine safety advocates well established Houses both clinicians and epidemiologists Houses immunization information system – familiar to most providers

Immunization Program cont. Provided oversight for adverse events during smallpox vaccination Staff already involved in monitoring VAERS reports and responding to significant adverse events Immunization Information System is located within the Immunization Program

Joint Decision The Immunization Program will continue to be responsible for adverse event reporting and monitoring and building infrastructure for public health emergencies Immunization program clinical consultant will collaborate with the Mass Prophylaxis Coordinator regarding vaccine safety and adverse events needs in a public health emergency

Current workgroup: Clinical staff with immunization background Epidemiologist IIS Manager

Needs Assessment How do providers currently report adverse events? What is the best venue for reporting adverse events when immunization activities are ramped up during a public health emergency? What systems exist and what are their capacities? –Federal –State

How do providers currently report adverse events? VFC site visit information shows that providers report knowing about and using VAERS for reporting adverse events. Most VAERS reports in MN are filed electronically The clinical consultant occasionally receives reports that are discussed with CDC staff

What is the best venue for reporting adverse events during a public health emergency? It should be familiar to providers –Clinics –Urgent Centers –Hospitals It should be easy to use

What is the best venue for reporting adverse events during a public health emergency? cont. It should be consistent with national systems There needs to be a clinical feedback mechanism to the provider reporting the event

Does such a system exist?

What is available at the Federal level? VAERS is accessible on line to anyone VAERS relies on reports that contain subjective data VAERS may be duplicative Vaccine Safety Datalink (VSD) –Provides real-time analysis of data CISA –Provides case-based clinical evaluation

State: Minnesota Immunization Information Connection (MIIC) Providers that vaccinate are familiar with MIIC It is set up in both public and private clinics Technical support exists, both regionally and at the state

MIIC cont. It has the capacity to add a data entry port for reporting It will be the main source for reporting doses given in mass prophylaxis There is no electronic connection between VAERS and MIIC

Conclusions: Minnesota does not have a state system for reporting adverse events If we develop a reporting system, we should use systems that already exists Avoid re-inventing the wheel - how can we expand on what already exists?

Step Two Determining MIIC capacity Determining if/what type of relationship with the MN VSD site would be helpful Determining whether a common dataset of adverse events exist Understanding where CDC is headed in building Adverse Event reporting within the context of a public health emergency

MIIC Capacity Inventory data can be preloaded and includes vaccine, manufacturer, lot number and expiration date 87% of Minnesota VFC providers* are enrolled in MIIC – but not all are actively entering data MIIC is enrolling adult immunization clinics and provider sites, including flu vendors, LTC, Urgent Care centers, pharmacists * Minnesota VFC providers include both public and private clinics that vaccinate MA enrolled patients – both children and adults

MIIC capacity cont. Minnesota is currently a sentinel site for IIS –Southwest region in the past –Metro region currently Hospital sentinel sites are entering seasonal influenza disease data into MIIC In the past 2 years MIIC and immunization program staff have promoted the importance of entering influenza clinic data into MIIC.

Health Partners Vaccine Safety Datalink Project MDH has a collaborative relationship with Health Partners through several of its programs Jim Nordin, MD is the project lead for Health Partners VDS project, and is a member of the MN Immunization Practices Advisory Committee

Meeting with Health Partners Common interests – –Real time data gathering –Building infrastructure –Providing data that is usable to both –Strengthening public/private partnership

Meeting with Health Partners cont. Different goals –HP would like to include broader data to do more comprehensive analysis of their current projects –MDH needs to determine how to develop basic reporting infrastructure that can be ramped up for public health emergencies

What is next? Discuss issues/questions with CDC Immunization Safety Office (ISO) Using influenza vaccination adverse events data to develop a pre-populated dataset Using the IIS sentinel site to pilot adverse event reporting Determining whether to focus on influenza-only AEs or any vaccine AE

Discussions with CDC ISO VAERS would still need to be used –Working on an IIS/VAERS interface Piloting surveillance using HL7 and ICD-9 medical coding signals Developing a Pass/active surveillance system model VAERS remains free text

Outstanding issues: How to keep AE symptom dataset streamlined and consistent with other datasets – need more national guidance Developing an internal clinical team to respond to AE reported during a pandemic or other public health emergency Learn from August training

Going forward Decision to proceed to develop a reporting system within MIIC. It will require: –Expanding inventory capacity into MIIC Working to get providers to use inventory feature –Improving flu vaccination data entry –Developing an influenza AE dataset Pilot sentinel site providers to enter AE reports Include Mass Prophylaxis Coordinator in team meetings

System for responding to AEs in a Public Health Emergency Public vaccination venues Adverse events will come from private sector – medical home providers, hospital emergency room Education will need to be directed at vaccinees and private medical sector so that reporting occurs

Acknowledgements: Cynthia Kenyon, MPH, Epidemiologist Emily Peterson, MIIC Manager